Activation of phospholipase A2 by amyloid beta-peptides in vitro

Biochemistry. 1996 Jul 23;35(29):9407-14. doi: 10.1021/bi960148o.

Abstract

Amyloid beta-peptides (A beta) are centrally involved in the pathogenesis of Alzheimer's disease. Using secretory phospholipase A2 (PLA2) from porcine pancreas as a model and in the presence of a limiting Ca2+ concentration of approximately 50 nM, the synthetic peptide A beta 1-42 activates the hydrolysis of the pyrene-labeled acidic phospholipid analog 1-palmitoyl-2-[(pyren-1-yl)]hexanoyl-sn-glycero-3-phosphoglycerol (PPHPG) maximally 2.3-fold, whereas an inhibition of PLA2 action by 50% on the corresponding phosphatidylcholine derivative (PPHPC) was observed. The above effects were evident at 0.24 nM A beta 1-42 corresponding to A beta 1-42:phospholipid and A beta 1-42:PLA2 molar ratios of 1:10 650 and 1:7.6, respectively. The presence of 10 mol % 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) in PPHPC reversed the inhibitory effect of A beta 1-42 peptide and for these vesicles the hydrolytic activity of PLA2 toward the fluorescent phosphatidylcholine was enhanced approximately 1.8-fold by A beta 1-42. In contrast, inclusion of 10 mol % POPG into PPHPG did not influence either the hydrolytic rate toward the latter lipid or the activating effect of A beta 1-42. Ca2+ concentrations exceeding 15 microM abolished the enhancing effect of A beta 1-42 on the hydrolysis of PPHPG whereas a slight activation of PPHPC hydrolysis now became evident. With limiting [Ca2+] preaggregated A beta 1-42 enhanced the hydrolysis of both PPHPG as well as PPHPC but the peptide concentrations required were higher by 3-4 orders of magnitude. The synthetic peptide A beta 25-35 corresponding to the hydrophobic membrane-spanning segment of the beta amyloid precursor protein activated PLA2 when using PPHPG as a substrate; however, compared to A beta 1-42 the extent of activation was less (approximately 2-fold) and required higher (1 nM) peptide. A beta 25-35 did not affect the hydrolysis of the phosphatidylcholine derivative. The hydrophilic peptide A beta 1-28 had no effect on PLA2-catalyzed hydrolysis of either PPHPG or PPHPC under the conditions used in the present study. Interestingly, the above activating effects of A beta 1-42 and A beta 25-35 on PLA2-catalyzed hydrolysis of the acidic phospholipid substrate parallel their toxicity on cultured neurons whereas A beta 1-28 had no influence either on cultured cells or on PLA2 activity.

MeSH terms

  • Alzheimer Disease / metabolism
  • Amino Acid Sequence
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Calcium / pharmacology
  • Edetic Acid / pharmacology
  • Enzyme Activation
  • Humans
  • Hydrolysis
  • Kinetics
  • Molecular Sequence Data
  • Pancreas / enzymology*
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Phosphatidylglycerols / metabolism
  • Phosphatidylglycerols / pharmacology
  • Phospholipases A / metabolism*
  • Phospholipases A2
  • Phospholipids / metabolism
  • Swine

Substances

  • 1-palmitoyl-2-((pyren-1-yl))hexanoyl-sn-glycero-3-phosphoglycerol
  • Amyloid beta-Peptides
  • Peptide Fragments
  • Phosphatidylglycerols
  • Phospholipids
  • amyloid beta-protein (1-42)
  • amyloid beta-protein (25-35)
  • 1-palmitoyl-2-oleoylglycero-3-phosphoglycerol
  • Edetic Acid
  • Phospholipases A
  • Phospholipases A2
  • Calcium